ReP USP - Resultado da busca

Filtros : "Indexado na Base de Dados Web of Science" "Oncotarget" Removidos: "Silva Júnior, Wilson Araújo da" "2021" Limpar

Filtros

USP affiliated authors
- kimura, edna teruko (~1)
- menck, carlos frederico martins (~1)
- nakaya, helder takashi imoto (~1)
Date published
- 2017 (~1)
- 2016 (~1)
Subjects
- dna (1)
- estresse oxidativo (1)
- fármacos (1)
- glioma (1)
- histologia (1)

Artigo de periodico
Down-regulation of 14q32-encoded miRNAs and tumor suppressorrole for miR-654-3p in papillary thyroid cancer (2017)
Geraldo, Murilo Vieira; Nakaya, Helder Takashi Imoto ; Kimura, Edna Teruko
Source: Oncotarget. Unidades: FCF, ICB
Assunto: HISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GERALDO, Murilo Vieira e NAKAYA, Helder Takashi Imoto e KIMURA, Edna Teruko. Down-regulation of 14q32-encoded miRNAs and tumor suppressorrole for miR-654-3p in papillary thyroid cancer. Oncotarget, v. 8, n. 6, p. 9597-9607, 2017Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.14162. Acesso em: 18 nov. 2024.
APA
Geraldo, M. V., Nakaya, H. T. I., & Kimura, E. T. (2017). Down-regulation of 14q32-encoded miRNAs and tumor suppressorrole for miR-654-3p in papillary thyroid cancer. Oncotarget, 8( 6), 9597-9607. doi:10.18632/oncotarget.14162
NLM
Geraldo MV, Nakaya HTI, Kimura ET. Down-regulation of 14q32-encoded miRNAs and tumor suppressorrole for miR-654-3p in papillary thyroid cancer [Internet]. Oncotarget. 2017 ; 8( 6): 9597-9607.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.14162
Vancouver
Geraldo MV, Nakaya HTI, Kimura ET. Down-regulation of 14q32-encoded miRNAs and tumor suppressorrole for miR-654-3p in papillary thyroid cancer [Internet]. Oncotarget. 2017 ; 8( 6): 9597-9607.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.14162
Artigo de periodico
NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells (2016)
Rocha, Clarissa Ribeiro Reily; Kajitani, Gustavo Satoru; Quinet, Annabel; Fortunato, Rodrigo Soares; Menck, Carlos Frederico Martins
Source: Oncotarget. Unidade: ICB
Subjects: GLIOMA, MELANOMA, NEOPLASIAS, FÁRMACOS, TERAPÊUTICA, DNA, ESTRESSE OXIDATIVO, MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Clarissa Ribeiro Reily et al. NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells. Oncotarget, v. 7, n. 30, p. 48081-48092, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.10129. Acesso em: 18 nov. 2024.
APA
Rocha, C. R. R., Kajitani, G. S., Quinet, A., Fortunato, R. S., & Menck, C. F. M. (2016). NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells. Oncotarget, 7( 30), 48081-48092. doi:10.18632/oncotarget.10129
NLM
Rocha CRR, Kajitani GS, Quinet A, Fortunato RS, Menck CFM. NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells [Internet]. Oncotarget. 2016 ; 7( 30): 48081-48092.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.10129
Vancouver
Rocha CRR, Kajitani GS, Quinet A, Fortunato RS, Menck CFM. NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells [Internet]. Oncotarget. 2016 ; 7( 30): 48081-48092.[citado 2024 nov. 18 ] Available from: https://doi.org/10.18632/oncotarget.10129

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024